On this page
16p11.2 duplication syndrome
This condition arises when a person has a duplication of genetic material at position 11.2 on the short arm of chromosome 16. It can affect intellectual development, speech, motor skills, and behaviour, though the specific features and their severity vary considerably between individuals.
Overview
16p11.2 duplication syndrome occurs when a segment of chromosome 16 is present in three copies instead of the usual two. This duplicated region contains multiple genes, and the additional genetic material disrupts typical development. The condition was more widely recognised following advances in chromosomal microarray technology, which can detect these small copy number changes that traditional karyotype testing might miss.
The duplication is estimated to occur in approximately 3 in every 10,000 individuals in the general population, though many cases may go undiagnosed if features are mild. Not everyone with the duplication experiences the same challenges - some individuals have significant developmental needs whilst others function well with minimal support. This variability makes it difficult to predict outcomes for any particular person with the condition, even within the same family.
Symptoms & clinical features
Developmental delay is one of the most common features, particularly affecting speech and language acquisition. Many children with 16p11.2 duplication syndrome begin speaking later than expected and may need ongoing speech therapy support. Motor skills can also be delayed, with some children taking longer to sit, crawl, or walk independently.
Behavioural and psychiatric features occur in a proportion of affected individuals. These may include attention difficulties, anxiety, features consistent with autism spectrum conditions, or obsessive tendencies. Some people experience seizures, though this is not universal. Physical features are generally subtle and non-specific, though low muscle tone and joint hypermobility have been reported. Unlike the reciprocal 16p11.2 deletion syndrome (which is associated with increased head size and obesity), the duplication may be associated with smaller head circumference and lower body weight in some individuals, though this pattern is not consistent across all cases.
Video: Genetics 101
Affected organs
The brain is the primary organ system affected, with the duplication impacting neurodevelopment in ways that influence learning, communication, and behaviour. Neuroimaging studies have identified structural brain differences in some individuals with the duplication, though these findings do not consistently predict clinical outcomes.
Whilst the condition primarily affects neurological development, other body systems are generally less severely impacted. Some individuals may have minor skeletal differences or subtle facial features, but these are typically not diagnostically distinctive on their own.
Risks & severity
The severity spectrum is notably broad. Some individuals require substantial educational and therapeutic support throughout life, whilst others achieve age-appropriate developmental milestones with minimal intervention. Intellectual ability ranges from significant learning disability to average or near-average cognitive function. School-age children often benefit from individualised educational plans tailored to their specific learning profile.
The long-term outlook depends heavily on the degree of developmental impact and the availability of appropriate support services. Many individuals with the duplication lead fulfilling lives, though they may face ongoing challenges with social communication, emotional regulation, or maintaining employment. Early intervention services - including speech therapy, occupational therapy, and educational support - may help maximise developmental potential, though research on optimal management strategies remains limited.
Genetic causes
The duplication arises from an error in chromosomal structure where a section of roughly 600,000 base pairs at position 11.2 on chromosome 16's short arm is present in three copies rather than two. This region contains approximately 25 genes, and having extra copies of these genes disrupts the usual balance of gene expression. The precise mechanisms linking this duplication to developmental differences are not fully understood, as the duplicated region includes multiple genes with diverse functions.
The duplication typically occurs as a spontaneous event during the formation of egg or sperm cells, though the exact timing and mechanism can vary. The region is flanked by repetitive DNA sequences that make it prone to rearrangement errors during cell division.
Inheritance pattern
Most cases of 16p11.2 duplication syndrome occur as new (de novo) events in an affected individual, meaning neither parent carries the duplication. However, the duplication can be inherited from a parent who also has it. When a parent carries the duplication, there is a 50% chance with each pregnancy of passing it on to a child, regardless of the child's sex.
Importantly, because the features associated with the duplication are so variable, a parent carrying the duplication may have very mild or even unrecognised features, yet their child could be more significantly affected - or vice versa. This unpredictability makes genetic counselling particularly valuable for families considering future pregnancies. Testing parents when a child is diagnosed helps clarify recurrence risks and may occasionally identify previously unrecognised features in the parent.
Diagnosis & testing
Diagnosis is typically made through chromosomal microarray analysis, a genetic test that can detect duplications and deletions too small to see on standard chromosome studies. This test is usually requested when a child shows developmental delay, learning difficulties, or behavioural concerns that prompt genetic investigation.
Within the NHS, referral to clinical genetics services typically occurs through paediatricians, neurodevelopmental specialists, or occasionally adult psychiatry services. Chromosomal microarray is available through the NHS Genomic Medicine Service for appropriate clinical indications. Once the duplication is identified, genetic counselling helps families understand the diagnosis, inheritance pattern, and implications for relatives.
Management & lifestyle
Management focuses on addressing each individual's specific developmental and medical needs rather than treating the duplication itself. Children typically benefit from multidisciplinary support, which may include speech and language therapy, occupational therapy, physiotherapy, and educational psychology input. Schools often implement Education, Health and Care Plans to ensure appropriate support.
If seizures occur, these are managed with standard anticonvulsant medications as directed by neurology services. Behavioural and psychiatric features may require specialist assessment through child and adolescent mental health services or adult mental health services, with interventions tailored to the individual presentation. Regular developmental monitoring helps identify emerging needs early. Families often find peer support groups valuable for connecting with others navigating similar challenges. Genetic counselling remains available to discuss family planning and testing options for relatives.
UK care pathway
Within the NHS Genomic Medicine Service, chromosomal microarray testing for suspected copy number variants is available through appropriate clinical referral pathways. Regional genetics services provide diagnostic testing, result interpretation, and ongoing genetic counselling for affected individuals and their families.
Clinical genetics appointments offer opportunities to discuss inheritance, recurrence risks, and testing options for family members. Genetic counsellors provide specialised support to help families understand the diagnosis and make informed decisions about family planning. Multidisciplinary clinics coordinating developmental, educational, and therapeutic services help ensure comprehensive care, though service models vary across different NHS regions.
Frequently asked questions
Will my child with 16p11.2 duplication syndrome be able to live independently as an adult?
Outcomes vary considerably between individuals. Some adults with the duplication live independently with minimal support, whilst others require ongoing assistance with daily activities. Early intervention and tailored educational support may help maximise your child's potential, though predicting long-term outcomes for any particular individual remains challenging.
Could I have the duplication without knowing it?
Yes, it is possible. Some parents only discover they carry the duplication when their child is diagnosed. The features can be very mild or even absent in some carriers, whilst others in the same family are more significantly affected. Testing parents helps clarify whether the duplication is inherited or occurred as a new event.
What is the difference between the 16p11.2 duplication and deletion?
The deletion involves missing genetic material from the same chromosomal region, whilst the duplication means extra copies. Though they affect the same region, deletion cases more typically show larger head size and tendency toward obesity, whereas duplication cases may have smaller head size and lower weight, though considerable variation exists in both conditions.
Are there treatments that can correct the duplication?
There are currently no treatments that can alter the underlying chromosomal duplication. Management focuses on supporting each individual's specific developmental, educational, and medical needs through therapies, educational interventions, and medical care as required. Research into the condition continues, but any future targeted therapies remain experimental.
References
- Vos N, Kleinendorst L, van der Laan L. Evaluation of 100 Dutch cases with 16p11.2 deletion and duplication syndromes; from clinical manifestations towards personalized treatment options. European journal of human genetics : EJHG. 2024. PMID: 38605127
- Levkova M, Stoyanova M, Staneva R. 16p11.2 Duplication Syndrome - a Case Report. Folia medica. 2021. PMID: 33650406
- Soliman P, Goin-Kochel RP, Alexander G. Motor Impairment in Children with 16p11.2-Deletion and -Duplication Syndromes. Journal of autism and developmental disorders. 2025. PMID: 40450614
- Colijn MA. 16p11.2 duplication syndrome-associated psychosis: An illustrative case and review of the literature. Schizophrenia research. 2025. PMID: 39673907
- Taylor CM, Finucane BM, Moreno-De-Luca A. Phenotypic shift in copy number variants: Evidence in 16p11.2 duplication syndrome. Genetics in medicine : official journal of the American College of Medical Genetics. 2023. PMID: 36609147
- Willis A, Pratt JA, Morris BJ. BDNF and JNK Signaling Modulate Cortical Interneuron and Perineuronal Net Development: Implications for Schizophrenia-Linked 16p11.2 Duplication Syndrome. Schizophrenia bulletin. 2021. PMID: 33067994
- Forrest MP, Dos Santos M, Piguel NH. Rescue of neuropsychiatric phenotypes in a mouse model of 16p11.2 duplication syndrome by genetic correction of an epilepsy network hub. Nature communications. 2023. PMID: 36808153
- Ueda K, Shinawi M, Pearson TS. Paroxysmal Kinesigenic Dyskinesia in Twins With Chromosome 16p11.2 Duplication Syndrome. Neurology. Genetics. 2021. PMID: 33987463